CUPROUS BROMIDE
General Information
| Mainterm | CUPROUS BROMIDE |
| CAS Reg.No.(or other ID) | 7787-70-4 |
| Regnum |
178.2010 |
From www.fda.gov
Computed Descriptors
Download SDF| 2D Structure | |
| CID | 24593 |
| IUPAC Name | bromocopper |
| InChI | InChI=1S/BrH.Cu/h1H;/q;+1/p-1 |
| InChI Key | NKNDPYCGAZPOFS-UHFFFAOYSA-M |
| Canonical SMILES | [Cu]Br |
| Molecular Formula | CuBr |
| Wikipedia | copper(I) bromide |
From Pubchem
Computed Properties
| Property Name | Property Value |
|---|---|
| Molecular Weight | 143.45 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 0 |
| Rotatable Bond Count | 0 |
| Complexity | 2.0 |
| CACTVS Substructure Key Fingerprint | A A A D c Q A A A A A A E A A E A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = = |
| Topological Polar Surface Area | 0.0 |
| Monoisotopic Mass | 141.848 |
| Exact Mass | 141.848 |
| Compound Is Canonicalized | True |
| Formal Charge | 0 |
| Heavy Atom Count | 2 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Isotope Atom Count | 0 |
| Covalently-Bonded Unit Count | 1 |
From Pubchem
ADMET Predicted Profile --- Classification
| Model | Result | Probability |
|---|---|---|
| Absorption | ||
| Blood-Brain Barrier | BBB+ | 0.9782 |
| Human Intestinal Absorption | HIA+ | 0.9942 |
| Caco-2 Permeability | Caco2+ | 0.6382 |
| P-glycoprotein Substrate | Non-substrate | 0.8977 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9694 |
| Non-inhibitor | 0.9882 | |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9111 |
| Distribution | ||
| Subcellular localization | Lysosome | 0.5657 |
| Metabolism | ||
| CYP450 2C9 Substrate | Non-substrate | 0.8641 |
| CYP450 2D6 Substrate | Non-substrate | 0.7263 |
| CYP450 3A4 Substrate | Non-substrate | 0.7752 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.6119 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.7162 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.8909 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.7722 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9003 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8855 |
| Excretion | ||
| Toxicity | ||
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9561 |
| Non-inhibitor | 0.9647 | |
| AMES Toxicity | Non AMES toxic | 0.5078 |
| Carcinogens | Carcinogens | 0.7432 |
| Fish Toxicity | High FHMT | 0.5738 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9629 |
| Honey Bee Toxicity | High HBT | 0.8161 |
| Biodegradation | Not ready biodegradable | 0.5670 |
| Acute Oral Toxicity | III | 0.7940 |
| Carcinogenicity (Three-class) | Warning | 0.4866 |
From admetSAR
ADMET Predicted Profile --- Regression
| Model | Value | Unit |
|---|---|---|
| Absorption | ||
| Aqueous solubility | -1.5456 | LogS |
| Caco-2 Permeability | 1.5098 | LogPapp, cm/s |
| Distribution | ||
| Metabolism | ||
| Excretion | ||
| Toxicity | ||
| Rat Acute Toxicity | 2.4230 | LD50, mol/kg |
| Fish Toxicity | 0.5018 | pLC50, mg/L |
| Tetrahymena Pyriformis Toxicity | 1.0348 | pIGC50, ug/L |
From admetSAR
Taxonomic Classification
| Kingdom | Inorganic compounds |
|---|---|
| Superclass | Mixed metal/non-metal compounds |
| Class | Transition metal salts |
| Subclass | Transition metal bromides |
| Intermediate Tree Nodes | Not available |
| Direct Parent | Transition metal bromides |
| Alternative Parents | |
| Molecular Framework | Not available |
| Substituents | Transition metal bromide - Inorganic salt |
| Description | This compound belongs to the class of inorganic compounds known as transition metal bromides. These are inorganic compounds in which the largest halogen atom is Bromine, and the heaviest metal atom a transition metal. |
From ClassyFire